The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

Completion of preclinical data package for RAD 402

by admin December 10, 2024
December 10, 2024
Completion of preclinical data package for RAD 402

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Lundin Mining to Divest Neves-Corvo and Zinkgruvan Operations for US$1.52 Billion
next post
Capital Raising and QSM Completion Update

Related Posts

Copper Price Forecast: Top Trends That Will Impact...

January 6, 2024

Chen Lin: Gold, Silver, Critical Minerals — Where...

March 12, 2025

Fintech Firm Velocity Raises US$10 Million for Enterprise...

May 29, 2025

Placement to Raise $1 Million

October 28, 2024

Investor Education: US Debt and Currency Collapse with...

December 7, 2023

$4.33M Funding Secured Through WCNOE Option Underwriting Agreement

February 20, 2024

Scoping Study Demonstrates Low Cost Potential (Replacement)

June 5, 2025

Top 3 Canadian Nickel Stocks of 2024

April 11, 2024

Australia, US Pen Rare Earth Metals Deal in...

October 21, 2025

Helium Evolution Announces Filing of Q1-2024 Financial Results

May 22, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,632)
    • Investing (5,287)
    • Politics (7,061)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved